The role of ANG-2 in this context remains less understood; nevertheless, several studies have suggested a correlation between escalated doses of ANG-2 and increased proliferation in several estrogen receptor-positive (ER+) breast cancer cell lines [62]. Here, ANGPT2 is linked to breast carcinoma.